IP Library Granted Patent US 7,208,501
Granted Patent B2
US 7,208,501 · App. 10/193,622 · Granted Apr 24, 2007

Quinuclidine carbamate derivatives and their use as M3 antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,208,501
App. No.
10/193,622
Granted
Apr 24, 2007
Kind
B2
Abstract

A compound which is a carbamate of formula: wherein R1 represents R2 represents a benzyl, phenethyl, furan-2-ylmethyl, furan-3-ylmethyl, thiophen-2-ylmethyl or thiophen-3-ylmethyl group or a straight or branched alkyl group having 3 to 8 carbon atoms, an alkenyl group having 3 to 8 carbon atoms, or a cycloalkyl group of 3 to 6 carbon atoms; p is 1 or 2 and the substitution in the azoniabicyclic ring may be in the 2, 3 or 4 position including all possible configurations of the asymmetric carbons; or a pharmaceutically acceptable salt thereof. The pharmaceutically acceptable salt may be of formula:

Claims (41)

1. A compound chosen from:

Benzylphenylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester Benzyl(4-fluorophenyl)carbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester Benzyl-p-tolylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester Butylphenylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester Phenylthiophen-2-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester Phenethyiphenylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester Pentylphenylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester Pent-4-enylphenylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester Phenylthiophen-3-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester Furan-2-ylmethylphenylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester Benzylphenylcarbamic acid 1-azabicyclo[2.2.2]oct-4-yl ester or a pharmaceutically acceptably salt thereof.

2. A compound chosen from: 3-(R)(Benzylphenylcarbamoyloxy)-3-(3-phenylallyl)-1-azoniabicyclo[2.2.2]octane bromide;

1-Allyl-3-(R)(benzylphenylcarbamoyloxy)-1-azoniabicyclo[2.2.2] octane bromide;

3-(R)(Benzylphenylcarbamoyloxy)-1-phenethyl-1-azoniabicyclo[2.2.2]octane bromide;

3-(R)(Benzylphenylcarbamoyloxy)-1-(3-thiophen-2-yl-propyl)- 1- azoniabicyclo[2.2.2] octane bromide;

3-(R)(Benzylphenylcarbamoyloxy)-1-(3-phenylpropyl)-1- azoniabicyclo[2.2.2]octane bromide;

3-(R)(Benzylphenylcarbamoyloxy)-1-(2-phenoxyethyl)-1-azoniabicyclo[2.2.2] octane bromide;

3-(R)(Butylphenylcarbomoyloxy)-1-(3-phenylallyl)-1-azoniabicyclo[2.2.2] octane bromide;

1-Allyl-3-(R)(butylphenylcarbamoyloxy)-1-azoniabicyclo[2.2.2] octane bromide;

3-(R)(Butylphenylcarbamoyloxy)-1-(2-phenoxyethyl)-1-azoniabicyclol[2.2.2] octane bromide;

3-(R)(Butylphenylcarbamoyloxy)-1-[3-(3-hydroxyphenoxy)propyl]-1-azoniabicyclo [2.2.2]octane bromide;

3-(R)(Butylphenylcarbamoyloxy)-1-[3-(4-fluorophenoxy)propyl]-1- azoniabicyclo[2.2.2] octane bromide;

3-(R)(Butylphenylcarbamoyloxy)-1-(3-thiophen-2-ylpropyl)-1-azoniabicyclo[2.2.2] octane bromide;

3-(R)(Butylphenylcarbamoyloxy)-1-(3-phenylpropyl]-1-azoniabicyclo[2.2.2]octane bromide;

3-(R)(Phenylthiophen-2-ylmethylcarbamoyloxy)-1-(3thiophen-2-ylpropyl)-1- azonia bicyclo[2.2.2]octane bromide;

1-(2-Phenoxy-ethyl)-3-(R)-(phenyl-thiophen-2-ylmethyl-carbamoyIoxy)-1- azoniabicyclo [2.2.2]octane bromide;

1-Allyl-3-(R)(phenylthiophen-2-ylmethylcarbamoyloxy)- 1- azoniabicyclo[2.2.2]octane bromide;

3-(R)(Phenethylphenylcarbamoyloxy)-1-(2-phenoxyethyl)-1- azoniabicyclo[2.2.2]octane trifluoroacetate;

1-Heptyl-3-(R)(pent-4-enylphenylcarbamoyloxy)-1-azoniabicyclo[2.2.2]octane trifluoroacetate;

1-Allyl-3-(R)-(phenyl-thiophen-3-ylmethyl-carbamoyloxy)-1-azonia- bicyclo[2.2.2]octane trifluoroacetate;

3-(R)(phenylthiophen-3-ylmethylcarbamoyloxy)-1-(3-thiophen-2-ylpropyl)-1- azonia bicyclo[2.2.2]octane bromide;

3-(R)(phenylthiophen-3-ylmethylcarbamoyloxy)-1-(2-phenoxyethyl)-1- azoniabicyclo [2.2.2]octane bromide; or

3-(R)(Furan-2-ylmethylphenylcarbamoyloxy)-1-(3-phenylpropyl)-1-azoniabicyclo [2.2.2]octane trifluoroacetate.

3. A compound according to claim 1 , wherein the compound is Benzylphenylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester.

4. A compound according to claim 1 , wherein the compound is a pharmaceutically acceptably salt of Benzylphenylcarbamic acid 1- azabicyclo[2.2.2]oct-3-(R)yl ester.

5. A compound according to claim 1 , wherein the compound is Butylphenylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester.

6. A compound according to claim 1 , wherein the compound is a pharmaceutically acceptably salt of Butylphenylcarbamic acid 1- azabicyclo[2.2.2]oct-3-(R)yl ester.

7. A compound according to claim 1 , wherein the compound is Phenylthiophen-2-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester.

8. A compound according to claim 1 , wherein the compound is a pharmaceutically acceptably salt of Phenylthiophen-2-ylmethylcarbamic acid 1- azabicyclo[2.2.2]oct-3-(R)yl ester.

9. A compound according to claim 1 , wherein the compound is Phenylthiophen-3-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester.

10. A compound according to claim 1 , wherein the compound is a pharmaceutically acceptably salt of Phenylthiophen-3-ylmethylcarbamic acid 1- azabicyclo[2.2.2]oct-3-(R)yl ester.

11. A salt according to claim 2 , wherein the salt is 3-(R)(Butylphenylcarbomoyloxy)-1-(3-phenylallyl)-1-azoniabicyclo[2.2.2]octane bromide.

12. A salt according to claim 2 , wherein the salt is 3-(R)(Butylphenylcarbamoyloxy)-1-(3-thiophen-2-ylpropyl)-1-azoniabicyclo[2.2.2] octane bromide.

13. A salt according to claim 2 , wherein the salt is 3-(R)(Benzylphenylcarbamoyloxy)-1-(3-thiophen-2-yl-propyl)-1- azoniabicyclo[2.2.2] octane bromide.

14. A salt according to claim 2 , wherein the salt is 3-(R)(Benzylphenylcarbamoyloxy)-1-(3-phenylpropyl)-1- azoniabicyclo[2.2.2]octane bromide.

15. A salt according to claim 2 , wherein the salt is 3-(R)(Benzylphenylcarbamoyloxy)-1-(2-phenoxyethyl)-1-azoniabicyclo[2.2.2]octane bromide.

16. A salt according to claim 2 , wherein the salt is 3-(R)(Phenylthiophen-2- ylmethylcarbamoyloxy)-1-(3-thiophen-2-ylpropyl)-1-azoniabicyclo[2.2.2]octane bromide.

17. A salt according to claim 2 , wherein the salt is 1-(2-Phenoxy-ethyl)-3- (R)-(phenyl-thiophen-2-ylmethyl-carbamoyloxy)-1-azoniabicyclo [2.2.2]octane bromide.

18. A salt according to claim 2 , wherein the salt is3-(R)(phenylthiophen-3- ylmethylcarbamoyloxy)-1-(3-thiophen-2-ylpropyl)-1-azoniabicyclo[2.2.2]octane bromide.

19. A salt according to claim 2 , wherein the salt is 3-(R)(phenylthiophen-3- ylmethylcarbamoyloxy)-1-(2-phenoxyethyl)-1-azoniabicyclo [2.2.2]octane bromide.

Assignments (6)
CHANGE OF NAME Recorded Feb 24, 2010
From: LABORATORIOS ALMIRALL, S.A.
To: ALMIRALL, S.A.
Reel/Frame 023973/0730 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2008
From: ALMIRALL AG
To: LABORATORIOS ALMIRALL S.A.
Reel/Frame 020859/0932 →
CHANGE OF NAME Recorded Jun 26, 2007
From: ALMIRALL PRODESFARMA AG
To: ALMIRALL AG
Reel/Frame 019479/0527 →
CHANGE OF NAME Recorded Jan 22, 2007
From: ALMIRALL PRODESFARMA AG
To: ALMIRALL AG
Reel/Frame 018786/0475 →
RE-RECORD TO CORRECT THE ADDRESS OF THE ASSIGNEE, PREVIOUSLY RECORDED ON REEL 013912 FRAME 0512, ASSIGNOR CONFIRMS THE ASSIGNMENT OF THE ENTIRE INTEREST. Recorded Dec 2, 2003
From: BUIL ALBERO, MARIA A.; FERNANDEZ FORNER, MARIA DOLORS; QUINONES, MARIA PRAT
To: ALMIRALL PRODESFARMA AG
Reel/Frame 014745/0660 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2003
From: ALBERO, MARIA ANTONIA BUIL; FORNER, MARIA DOLORS FERNANDEZ; QUINONES, MARIA PRAT
To: ALMIRALL PRODESFARMA AG
Reel/Frame 013912/0512 →